GGrantIndex
← Leaderboards

Alan R. Cohen

Children'S Hospital Of Philadelphia

$10,567,103
Attributed
$10,567,103
Total exposure
10
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $900.3K · FY200512
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$9,998,649 · 10
CDC$906,250 · 1

By mechanism

K12$3,717,396 · 1
U01$2,810,962 · 2
T32$2,263,284 · 1
R01$1,098,386 · 1
P01$633,634 · 1
P30$337,796 · 1

Top collaborators

No co-investigators on record.

Most similar at Children'S Hospital Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectHuman Therapy EvaluationThalassemiaPediatricsTrainingMentorsMolecularPhiladelphiaPediatricianExtramural ActivitiesInstitutionBlood Disorder ChemotherapyAreaEquilibriumFundingEffectivenessChild Health CareFacultyChildhoodGrantEnvironmentChildNci Scholars Program

Grant awards (44)

CHOP Pediatrics Scholars Program$388,953
K12 · FY2012 · HD · contact PI
CHOP Institutional Training in Pediatrics$273,699
T32 · FY2012 · HD · contact PI
CHOP Institutional Training in Pediatrics$233,977
T32 · FY2011 · HD · contact PI
CHOP Pediatrics Scholars Program$174,857
K12 · FY2011 · HD · contact PI
Prevention of the Complications of Thalassemia$150,000
U01 · FY2011 · DD · contact PI
CHOP Pediatrics Scholars Program$320,640
K12 · FY2010 · HD · contact PI
CHOP Institutional Training in Pediatrics$224,198
T32 · FY2010 · HD · contact PI
Prevention of the Complications of Thalassemia$150,000
U01 · FY2010 · DD · contact PI
CHOP Pediatrics Scholars Program$432,000
K12 · FY2009 · HD · contact PI
CHOP Institutional Training in Pediatrics$268,269
T32 · FY2009 · HD · contact PI
Prevention of the Complications of Thalassemia$200,000
U01 · FY2009 · DD · contact PI
CHOP Pediatrics Scholars Program$432,000
K12 · FY2008 · HD · contact PI
Prevention of the Complications of Thalassemia$200,000
U01 · FY2008 · DD · contact PI
CHOP Pediatric Scholars Program$399,211
K12 · FY2007 · HD · contact PI
Prevention of the Complications of Thalassemia$206,250
U01 · FY2007 · DD · contact PI
CHOP Pediatric Scholars Program$376,351
K12 · FY2006 · HD · contact PI
CHOP Institutional Training in Pediatric Research$264,175
T32 · FY2006 · HD · contact PI
CHOP Pediatric Scholars Program$398,541
K12 · FY2005 · HD
CHOP Institutional Training in Pediatric Research$258,748
T32 · FY2005 · HD
Thalassemia Clinical Research Network$185,711
U01 · FY2005 · HL
CROSS-SECTIONAL OBSERVATIONAL STUDY OF LOW BONE MASS IN THALASSEMIA$10,751
M01 · FY2005 · RR
STUDY OF RESPONSE OF OXIDANT-STRESS INDUCED INJURY AND MITOCHONDRAL DYSFUNCTION$5,160
M01 · FY2005 · RR
CHOP Pediatric Scholars Program$398,170
K12 · FY2004 · HD
THE MID-ATLANTIC THALASSEMIA CONSORTIUM$338,404
U01 · FY2004 · HL
CHOP Institutional Training in Pediatric Research$257,872
T32 · FY2004 · HD
Cross-sectional observational study of low bone mass in Thalassemia$24,187
M01 · FY2004 · RR
Study of response of oxidant-stress induced injury and mitochondral dysfunction$2,783
M01 · FY2004 · RR
Pediatric Scholars Program$396,673
K12 · FY2003 · HD
THE MID-ATLANTIC THALASSEMIA CONSORTIUM$360,600
U01 · FY2003 · HL
CHOP Institutional Training in Pediatric Research$282,804
T32 · FY2003 · HD
ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIA$379,050
R01 · FY2002 · HL
THE MID-ATLANTIC THALASSEMIA CONSORTIUM$350,097
U01 · FY2002 · HL
MOLECULAR APPROACHES TO PEDIATRIC SCIENCE - CHRC$337,796
P30 · FY2002 · HD
CHOP Institutional Training in Pediatric Research$199,542
T32 · FY2002 · HD
Human application of AAV mediated muscle directed factor IX gene transfer$0
P01 · FY2002 · HL
OSTEOPOROSIS IN THALASSEMIA$0
M01 · FY2002 · RR
Human application of AAV mediated muscle directed factor IX gene transfer$380,508
P01 · FY2001 · HL
ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIA$363,715
R01 · FY2001 · HL
THE MID-ATLANTIC THALASSEMIA CONSORTIUM$339,900
U01 · FY2001 · HL
Human application of AAV mediated muscle directed factor IX gene transfer$0
P01 · FY2001 · HL
ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIA$355,621
R01 · FY2000 · HL
THE MID-ATLANTIC THALASSEMIA CONSORTIUM$330,000
U01 · FY2000 · HL
Human application of AAV mediated muscle directed factor IX gene transfer$253,126
P01 · FY2000 · HL
OSTEOPOROSIS IN THALASSEMIA$560
M01 · FY2000 · RR